Chronic ouabain treatment exacerbates blood pressure elevation in spontaneously hypertensive rats: the role of vascular mechanisms

Journal of Hypertension

Volumn 27, Issue 6, 2009, Pages 1233-1242

  Xavier, Fabiano E ^b   Davel, Ana Paula C ^a   Fukuda, Livia E ^a   Rossoni, Luciana V ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b FEDERAL UNIVERSITY OF PERNAMBUCO   (Brazil)

Author keywords

Cyclooxygenase 2; Endothelial dysfunction; Hypertension; Ouabain; Prostanoids

Indexed keywords

ACETYLCHOLINE; CYCLOOXYGENASE 2; ENDOTHELIAL NITRIC OXIDE SYNTHASE; INDOMETACIN; N(G) NITROARGININE METHYL ESTER; OUABAIN; PHENYLEPHRINE; RIDOGREL; TETRYLAMMONIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY CONSTRICTION; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD VESSEL REACTIVITY; BODY WEIGHT; CONTROLLED STUDY; ENZYME INHIBITION; ESSENTIAL HYPERTENSION; HEMODYNAMIC PARAMETERS; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; WESTERN BLOTTING;

EID: 67649639360     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/HJH.0b013e32832a391f     Document Type: Article

References (42)

1. Hamlyn JM, Hamilton BP, Manunta P. Endogenous ouabain, sodium balance and blood pressure: a review and a hypothesis. J Hypertens 1996; 14:151-171.
2. Schoner W, Scheiner-Bobis G. Endogenous and exogenous cardiac glycosides: their roles in hypertension, salt metabolism, and cell growth. Am J Physiol 2007; 293:C509-C536.
3. Bagrov AY, Shapiro Jl. Endogenous digitalis: pathophysiologic roles and therapeutic applications. Nat Clin Pract Nephrol 2008; 4:378-392.
4. 2+ stores and cell responsiveness. Am J Physiol 1993; 264:C1367-C1387.
5. Overbeck HW, Pamnani MB, Akera T, Brody TM, Haddy FJ. Depressed function of a ouabain-sensitive sodium-potassium pump in blood vessels from renal hypertensive dogs. Circ Res 1976; 38 (suppl 2):48-52.
6. +) ATPase associated with essential hypertension. Nature 1982; 300:650-652.
7. Manunta P, Maillard M, Tantardini C, Simonini M, Lanzani C, Citterio L, et al. Relationships among endogenous ouabain, alpha-adducin polymorphisms and renal sodium handling in primary hypertension. J Hypertens 2008; 26:914-920.
8. Huang BS, Huang X, Harmsen E, Leenen FHH. Chronic central versus peripheral ouabain, blood pressure, and sympathetic activity in rats. Hypertension 1994; 23 (part 2):1087-1090.
9. Manunta P, Rogowski AC, Hamilton BP, Hamlyn JM. Ouabain-induced hypertension in the rat: relationships among plasma and tissue ouabain and blood pressure. J Hypertens 1994; 12:549-560.
10. Kimura K, Manunta P, Hamilton BP, Hamlyn JM. Different effects of in vivo ouabain and digoxin on renal artery function and blood pressure in the rat. Hypertens Res 2000; 23:S67-S76.
11. Rossoni LV, Pinto VD, Vassallo DV. Effects of small doses of ouabain on arterial blood pressure of anesthetized hypertensive and normotensive rats. Braz J Med Biol Res 2001; 34:1065-1077.
12. +-ATPase in ouabain-induced hypertension. Br J Pharmacol 2002; 135:771-781.
13. Rossoni LV, Salaices M, Miguel M, Briones AM, Barker LA, Vassallo DV, Alonso MJ. Ouabain-induced hypertension is accompanied by increases in endothelial vasodilator factors. Am J Physiol 2002; 283:H2110-H211 8.
14. Rossoni LV, dos Santos L, Barker LA, Vassallo DV. Ouabain changes arterial blood pressure and vascular reactivity to phenylephrine in L-NAME induced hypertension. J Cardiovasc Pharmacol 2003; 41:105-116.
15. Rossoni LV, Xavier FE, Moreira CM, Falcochio D, Amanso AM, Tanoue CU, et al. Ouabain-induced hypertension enhances left ventricular contractility in rats. Life Sci 2006; 79:1537-1545.
16. Xavier FE, Rossoni LV, Alonso MJ, Balfagon G, Vassallo DV, Salaices M. Ouabain-induced hypertension alters the participation of endothelial factors in alpha-adrenergic responses differently in rat resistance and conductance mesenteric arteries. Br J Pharmacol 2004; 143:215-225.
17. Xavier FE, Yogi A, Callera GE, Tostes RC, Alvarez Y, Salaices M, et al. Contribution of the endothelin and renin-angiotensin systems to the vascular changes in rats chronically treated with ouabain. Br J Pharmacol 2004; 143:794-802.
18. Briones AM, Xavier FE, Arribas SM, González MC, Rossoni LV, Alonso MJ, Salaices M. Alterations in structure and mechanics of resistance arteries from ouabain induced hypertensive rats. Am J Physiol 2006; 291:H193-H201.
19. Huang BS, Leenen FHH. Brain renin-angiotensin system and ouabain induced sympathetic hyperactivity and hypertension in Wistar rats. Hypertension 1999; 34:107-11 2.
20. Zhang J, Leenen FHH. AT(1) receptor blockers prevent sympathetic hyperactivity and hypertension by chronic ouabain and hypertonic saline. Am J Physiol 2001; 280:H131 8-H1323.
21. Di Filippo C, Filippelli A, Rinaldi B, Piegari E, Esposito F, Rossi F, D'Amico M. Chronic peripheral ouabain treatment affects the brain endothelin system of rats. J Hypertens 2003; 21:747-753.
22. Rossoni LV, Cunha V, França A, Vassallo DV. The influence of nanomolar ouabain on vascular pressor response is modulated by the endothelium. J Cardiovasc Pharmacol 1999; 34:887-892.
23. Marín J, Sánchez-Ferrer CF, Salaices M. Effects of ouabain on isolated cerebral and femoral arteries of the cat: a functional and biochemical study. Br J Pharmacol 1988; 93:43-52.
24. Overbeck HW. Effect of ouabain on arteriolar responses to norepinephrine in chronic, benign, volume-expanded hypertension. Hypertension 1984; 6 (suppl 1):82-87.
25. Songu-Mize E, Vassallo DV, Rashed SM, Varner KJ. Ouabain amplifies contractile responses to phenylephrine in rat tail arteries in hypertension. J Basic Clin Physiol Pharmacol 1995; 6:309-31 9.
26. Ponte A, Marín J, Arribas S, González S, Barrús MT, Salaices M, Sánchez-Ferrer CF. Endothelial modulation of ouabain-induced contraction and sodium pump activity in aortas of normotensive Wistar-Kyoto and spontaneously hypertensive rats. J Vasc Res 1996; 33:1 64-174.
27. Ceron PI, Bendhack LM. Increased contractile response induced with ouabain is abolished by thapsigargin in aorta of renal hypertensive rats. Gen Pharmacol 1997; 29:707-712.
28. Vassallo DV, Songu-Mize E, Rossoni LV, Amaral SMC. Effects of ouabain on vascular reactivity. Braz J Med Biol Res 1997; 30:545-552.
29. Padilha A, Rossoni LV, Xavier FE, Vassallo DV. Ouabain at nanomolar concentration promotes the synthesis and release of angiotensin II from the endothelium of the tail vascular bed of spontaneously hypertensive rats. J Cardiovasc Pharmacol 2004; 44:372-380.
30. Hulthen UL, Bolli P, Kiowski W, Buhler FR. Fore-arm vasoconstrictor response to ouabain: studies in patients with mild and moderate essential hypertension. J Cardiovasc Pharmacol 1984; 6:75-81.
31. Lüscher TF, Vanhoutte PM. Endothelium-dependent contractions to acetylcholine in the aorta of spontaneously hypertensive rat. Hypertension 1986; 8:344-348.
32. Panza JA, Quyyumi AA, Brush JE, Epstein SE. Abnormal endothelium dependent vascular relaxation in patients with essential hypertension. N Engl J Med 1990; 323:22-27.
33. Taddei S, Virdis A, Mattei P, Salvetti A. Vasodilation to acetylcholine in primary and secondary forms of human hypertension. Hypertension 1 993; 21:929-933.
34. Félétou M, Vanhoutte PM. Endothelial dysfunction: a multifaceted disorder (the Wiggers Award Lecture). Am J Physiol Heart Circ Physiol 2006; 291:H985-H1002.
35. Huang BS, Leenen FHH. Brain 'ouabain' and angiotensin II in salt-sensitive hypertension in spontaneously hypertensive rats. Hypertension 1996; 28:1005-1012.
36. Van Huysse JW. Endogenous brain Na pumps, brain ouabain-like substance and the alpha2 isoform in salt-dependent hypertension. Pathophysiology 2007; 14:213-220.
37. Tabernero A, Giraldo J, Vila E. Modelling the changes due to the endothelium and hypertension in the a-adrenoreceptor-mediated responses of rat aorta. J Auton Pharmacol 1 999; 19:21 9-228.
38. Alvarez Y, Briones AM, Balfagon G, Alonso MJ, Salaices M. Hypertension increases the participation of vasoconstrictor prostanoids from cyclooxygenase-2 in phenylephrine responses. J Hypertens 2005; 23:767-777.
39. dos Santos L, Xavier FE, Vassallo DV, Rossoni LV. Cyclooxygenase pathway is involved in the vascular reactivity and inhibition of the Na+, K+-ATPase activity in the tail artery from L-NAME-treated rats. Life Sci 2003; 74:613-627.
40. Xavier FE, Aras-Lopez R, Arroyo-Villa I, Campo LD, Salaices M, Rossoni LV, et al. Aldosterone induces endothelial dysfunction in resistance arteries from normotensive and hypertensive rats by increasing thromboxane A(2) and prostacyclin. Br J Pharmacol 2008; 154:1225-1235.
41. Tang EH, Jensen BL, Skott O, Leung GP, Feletou M, Man RY, Vanhoutte PM. The role of prostaglandin E and thromboxane-prostanoid receptors in the response to prostaglandin E2 in the aorta of Wistar Kyoto rats and spontaneously hypertensive rats. Cardiovasc Res 2008; 78:130-138.
42. +-ATPase on the prostacyclin generation of cultured human vascular endothelial cells. Life Sci 1987; 40:351-357.